Postinjection delirium/sedation syndrome in a transgender man undergoing hormone therapy

• Váldodahkkit: Joshua Gerving, PharmD, BCPS, BCPP (Dahkki), Heather Walser, PharmD, BCPP (Dahkki), Anne C. Kelly, MD (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: American Association of Psychiatric Pharmacists, 2023-08-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background: Long-acting injectable medications have become an important tool in the treatment of schizophrenia and schizoaffective disorder due to the high rates of medication nonadherence. Olanzapine long-acting injection (OLAI) is a useful therapeutic option for patients who have good tolerability...